{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:26:59Z","timestamp":1769524019822,"version":"3.49.0"},"reference-count":29,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with poor prognosis and progression to lung fibrosis related to genetic factors as well as environmental factors. In fact, it was discovered that in South Korea many people who used humidifier disinfectants containing polyhexamethylene guanidine (PHMG), died of lung fibrosis. Currently two anti-fibrotic drugs, pirfenidone and nintedanib, have been approved by the FDA, but unfortunately, do not cure the disease. Since the histone deacetylase (HDAC) activity is associated with progression to chronic diseases and with fibrotic phenomena in the kidney, heart and lung tissues, we investigated the anti-fibrotic effects of CG-745, an HDAC inhibitor. After lung fibrosis was induced in two animal models by bleomycin and PHMG instillation, the regulation of fibrosis and epithelial mesenchymal transition (EMT)-related markers was assessed. CG-745 exhibited potent prevention of collagen production, inflammatory cell accumulation, and cytokines release in both models. Additionally, N-cadherin and vimentin expression were lowered significantly by the treatment of CG-745. The anti-fibrotic effects of CG-745 proven by the EMT regulation may suggest a potential therapeutic effect of CG-745 on lung fibrosis.<\/jats:p>","DOI":"10.3390\/molecules24152792","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T11:37:07Z","timestamp":1564573027000},"page":"2792","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The Anti-Fibrotic Effects of CG-745, an HDAC Inhibitor, in Bleomycin and PHMG-Induced Mouse Models"],"prefix":"10.3390","volume":"24","author":[{"given":"Young-Suk","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University, School of Medicine, Iksan, Jeonbuk 54538, Korea"},{"name":"Medical Convergence Research Center, Wonkwang University Hospital, Iksan, Jeonbuk 54538, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4768-0608","authenticated-orcid":false,"given":"Hyunju","family":"Cha","sequence":"additional","affiliation":[{"name":"CrystalGenomics, Inc. Bundanggu, Seongnamsi, Gyeonggido 13488, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3912-162X","authenticated-orcid":false,"given":"Hyo-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University, School of Medicine, Iksan, Jeonbuk 54538, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joong-Myung","family":"Cho","sequence":"additional","affiliation":[{"name":"CrystalGenomics, Inc. Bundanggu, Seongnamsi, Gyeonggido 13488, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hak-Ryul","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University, School of Medicine, Iksan, Jeonbuk 54538, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2958","article-title":"Strategies for treating idiopathic pulmonary fibrosis","volume":"9","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic Pulmonary Fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1164\/rccm.201504-0818OC","article-title":"Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation","volume":"192","author":"Esposito","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"108870","DOI":"10.1016\/j.biopha.2019.108870","article-title":"Protective effects of Rosavin on bleomycin-induced pulmonary fibrosis via suppressing fibrotic and inflammatory signaling pathways in mice","volume":"115","author":"Xin","year":"2019","journal-title":"Biomed. Pharmacother"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/thoraxjnl-2013-204132","article-title":"A cluster of lung injury cases associated with home humidifier use: An epidemiological investigation","volume":"69","author":"Kim","year":"2014","journal-title":"Thorax"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201306-1088OC","article-title":"Humidifier disinfectant-associated children\u2019s interstitial lung disease","volume":"189","author":"Kim","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.scitotenv.2017.04.040","article-title":"Types of household humidifier disinfectant and associated risk of lung injury (HDLI) in South Korea","volume":"596\u2013597","author":"Park","year":"2017","journal-title":"Sci. Total Environ."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00204-015-1486-9","article-title":"Polyhexamethylene guanidine phosphate aerosol particles induce pulmonary inflammatory and fibrotic responses","volume":"90","author":"Kim","year":"2016","journal-title":"Arch. Toxicol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/thoraxjnl-2014-206411","article-title":"Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis","volume":"70","author":"Korfei","year":"2015","journal-title":"Thorax"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1038\/cddis.2013.146","article-title":"Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts","volume":"4","author":"Huang","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1183\/09031936.00095113","article-title":"Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice","volume":"43","author":"Sanders","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bae, E.H., Kim, I.J., Song, J.H., Choi, H.S., Kim, C.S., Eom, G.H., Kim, I., Cha, H., Cho, J.M., and Ma, S.K. (2019). Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030508"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11546","DOI":"10.1038\/s41598-018-30008-5","article-title":"Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease","volume":"8","author":"Choi","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yjmcc.2019.04.003","article-title":"Histone deacetylases in cardiovascular and metabolic diseases","volume":"130","author":"Bagchi","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Korfei, M., Stelmaszek, D., MacKenzie, B., Skwarna, S., Chillappagari, S., Bach, A.C., Ruppert, C., Saito, S., Mahavadi, P., and Klepetko, W. (2018). Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0207915"},{"key":"ref_17","first-page":"8797206","article-title":"HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases","volume":"2016","author":"Hull","year":"2016","journal-title":"Biom.Res. Int."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Saito, S., Zhuang, Y., Shan, B., Danchuk, S., Luo, F., Korfei, M., Guenther, A., and Lasky, J.A. (2017). Tubastatin ameliorates pulmonary fibrosis by targeting the TGF\u03b2-PI3K-Akt pathway. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186615"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"L864","DOI":"10.1152\/ajplung.00128.2009","article-title":"Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition","volume":"297","author":"Guo","year":"2009","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-6-56","article-title":"TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)","volume":"6","author":"Kasai","year":"2005","journal-title":"Respir. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1073\/pnas.0605669103","article-title":"Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix","volume":"103","author":"Kim","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"41615","DOI":"10.1038\/srep41615","article-title":"A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1111\/bph.12590","article-title":"A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells","volume":"171","author":"Park","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding","volume":"113","author":"Kee","year":"2006","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wu, W.P., Tsai, Y.G., Lin, T.Y., Wu, M.J., and Lin, C.Y. (2017). The attenuation of renal fibrosis by histone deacetylase inhibitors is associated with the plasticity of FOXP3(+)IL-17(+) T cells. BMC Nephrol., 18.","DOI":"10.1186\/s12882-017-0630-6"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/15\/2792\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:11:48Z","timestamp":1760188308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/15\/2792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":29,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["molecules24152792"],"URL":"https:\/\/doi.org\/10.3390\/molecules24152792","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,31]]}}}